iVeena

Salt Lake City, United States

iVeena develops ocular drug products that eliminate the need for eye drop application and painful injections.

$3.0M raised

Feb 2025

Series B

Top Investors

National Science FoundationPark City AngelsMountain Pacific PartnersPC SquaredLLCTechnology Venture Corporation

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has iVeena raised?

iVeena has raised $3.0M in total funding. The most recent round was Series B. The last funding was announced in February 2025.

Who are iVeena's investors?

iVeena's investors include National Science Foundation, Park City Angels, Mountain Pacific Partners, PC Squared, LLC, Technology Venture Corporation.

Where is iVeena headquartered?

iVeena is headquartered in Salt Lake City, United States.

What does iVeena do?

iVeena develops ocular drug products that eliminate the need for eye drop application and painful injections.

What stage is iVeena at?

iVeena is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 5, 2025.

MLA

"iVeena — Funding & Investors." VCBacked, February 5, 2025, https://www.vcbacked.co/company/iveena. Accessed June 4, 2026.

APA

VCBacked. (2025). iVeena — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/iveena

Wikipedia (cite web)

{{cite web |title=iVeena — Funding & Investors |url=https://www.vcbacked.co/company/iveena |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 5, 2025.